{"data":[{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":29571826,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":29571826,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":29571826,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":27215960,"percentOfClass":9.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-26-352642","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":18490636,"percentOfClass":6.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-26-352642","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":18490636,"percentOfClass":6.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-26-352642","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":18490636,"percentOfClass":6.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":16031969,"percentOfClass":5.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":16031969,"percentOfClass":5.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":11183991,"percentOfClass":3.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":11183991,"percentOfClass":3.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":1887918,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1887918,"percentOfClass":0.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0002012383-26-002467","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":16124696,"percentOfClass":5.5,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":21342442,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":21342442,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":21342442,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000155","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":21342442,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000919574-26-003489","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":43931,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000919574-26-003489","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":43931,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000919574-26-003489","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":"00534A102","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":43931,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":28857208,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":28857208,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":28857208,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001346824-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":28857208,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":25525000,"percentOfClass":9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":25525000,"percentOfClass":9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":25525000,"percentOfClass":9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":23573615,"percentOfClass":8.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000902664-26-001128","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":16653036,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000902664-26-001128","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":16653036,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000902664-26-001128","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":16653036,"percentOfClass":6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":13619218,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":13619218,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":9954397,"percentOfClass":3.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":9954397,"percentOfClass":3.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1563852,"percentOfClass":0.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-26-000469","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":1563852,"percentOfClass":0.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001012975-26-000135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Maverick Capital Management, LLC","reportingCik":null,"personType":"HC","sharesOwned":18970913,"percentOfClass":6.7,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001012975-26-000135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Maverick Capital, Ltd.","reportingCik":null,"personType":"IA","sharesOwned":18970913,"percentOfClass":6.7,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001012975-26-000135","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Lee S. Ainslie III","reportingCik":null,"personType":"IN","sharesOwned":18970913,"percentOfClass":6.7,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Guy Levy","reportingCik":null,"personType":"IN","sharesOwned":7708727,"percentOfClass":2.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":7708727,"percentOfClass":2.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":7708727,"percentOfClass":2.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":6028567,"percentOfClass":2.2,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":6028567,"percentOfClass":2.2,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":6028567,"percentOfClass":2.2,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus PE GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1680160,"percentOfClass":0.6,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus Private Equity GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1680160,"percentOfClass":0.6,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-26-015651","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Soleus Private Equity Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1680160,"percentOfClass":0.6,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-335350","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-23","reportingPerson":"Adimab, LLC","reportingCik":"0001545672","personType":"OO","sharesOwned":20262170,"percentOfClass":7.3,"filedAt":"2025-12-29","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-297003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-18","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":21785166,"percentOfClass":7.9,"filedAt":"2025-11-25","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-297003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-18","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":21785166,"percentOfClass":7.9,"filedAt":"2025-11-25","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-297003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-18","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":21785166,"percentOfClass":7.9,"filedAt":"2025-11-25","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-288171","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-17","reportingPerson":"Adimab, LLC","reportingCik":"0001545672","personType":"OO","sharesOwned":20454490,"percentOfClass":8.8,"filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001274173-25-000285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":25383077,"percentOfClass":12.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001274173-25-000285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Janus Henderson Biotech Innovation Master Fund Ltd","reportingCik":null,"personType":"IV","sharesOwned":21576145,"percentOfClass":10.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000902664-25-004982","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":20372479,"percentOfClass":9.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000902664-25-004982","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":20372479,"percentOfClass":9.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000902664-25-004982","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":20372479,"percentOfClass":9.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001172661-25-004828","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001172661-25-004828","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001172661-25-004828","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-277894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Mithril II UGP LLC","reportingCik":"0001878230","personType":"OO","sharesOwned":11241580,"percentOfClass":4.8,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-277894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Mithril II GP LP","reportingCik":"0001878232","personType":"PN","sharesOwned":11241580,"percentOfClass":4.8,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-277894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Mithril II LP","reportingCik":"0001669609","personType":"PN","sharesOwned":11241580,"percentOfClass":4.8,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-277894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Peter Thiel","reportingCik":"0001211060","personType":"IN","sharesOwned":11241580,"percentOfClass":4.8,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-277894","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Ajay Royan","reportingCik":"0001875614","personType":"IN","sharesOwned":11241580,"percentOfClass":4.8,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Terrance McGuire","reportingCik":"0001117003","personType":"IN","sharesOwned":7008590,"percentOfClass":3,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Jonathan Flint","reportingCik":"0001295676","personType":"IN","sharesOwned":3233580,"percentOfClass":1.4,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Venture Management Co. V, L.L.C.","reportingCik":"0001439589","personType":null,"sharesOwned":3233580,"percentOfClass":1.4,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Venture Partners V, L.P.","reportingCik":"0001439590","personType":"PN","sharesOwned":3120194,"percentOfClass":1.3,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Partners GP IX, L.L.C.","reportingCik":"0001877150","personType":"OO","sharesOwned":3066757,"percentOfClass":1.3,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Partners IX, L.P.","reportingCik":"0001779755","personType":"PN","sharesOwned":3066757,"percentOfClass":1.3,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Healthcare Technology Opportunities Fund, L.P.","reportingCik":"0001815669","personType":"PN","sharesOwned":497660,"percentOfClass":0.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Healthcare Technology Opportunities Fund GP, L.L.C.","reportingCik":"0001815675","personType":"OO","sharesOwned":497660,"percentOfClass":0.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Venture Partners Entrepreneurs' Fund V, L.P.","reportingCik":"0001371245","personType":"PN","sharesOwned":60814,"percentOfClass":0,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Venture Partners Special Founders' Fund V, L.P.","reportingCik":"0001439586","personType":"PN","sharesOwned":31198,"percentOfClass":0,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001193125-25-272648","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-08-22","reportingPerson":"Polaris Venture Partners Founders' Fund V, L.P.","reportingCik":"0001439588","personType":"PN","sharesOwned":21374,"percentOfClass":0,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":16000000,"percentOfClass":7.4,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":16000000,"percentOfClass":7.4,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":16000000,"percentOfClass":7.4,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":14757384,"percentOfClass":6.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":8545920,"percentOfClass":4,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":8545920,"percentOfClass":4,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":6211464,"percentOfClass":2.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":6211464,"percentOfClass":2.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":991974,"percentOfClass":0.5,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0000921895-25-002791","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"Invivyd, Inc.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-10-15","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":991974,"percentOfClass":0.5,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Guy Levy","reportingCik":null,"personType":"IN","sharesOwned":10850000,"percentOfClass":5.1,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":10850000,"percentOfClass":5.1,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10850000,"percentOfClass":5.1,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":7993000,"percentOfClass":3.7,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":7993000,"percentOfClass":3.7,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":7993000,"percentOfClass":3.7,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus PE GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":2857000,"percentOfClass":1.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus Private Equity GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":2857000,"percentOfClass":1.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"},{"accessionNo":"0001213900-25-098418","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001832038","issuerName":"INVIVYD, INC.","ticker":"IVVD","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-10","reportingPerson":"Soleus Private Equity Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2857000,"percentOfClass":1.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd"}],"updatedAt":"2026-11-05T14:32:55.993Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ivvd","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}